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ABSTRACT
YES-associated protein (YAP) is a major effector protein of the Hippo tumor 
suppressor pathway, and is phosphorylated by the serine/threonine kinase LATS. 
Their binding is mediated by the interaction between WW domains of YAP and PPxY 
motifs of LATS. Their isoforms, YAP2 and LATS1 contain two WW domains and two 
PPxY motifs respectively. Here, we report the study of the interaction of these 
domains both in vitro and in human cell lines, to better understand the mechanism 
of their binding. We show that there is a reciprocal binding preference of YAP2-
WW1 with LATS1-PPxY2, and YAP2-WW2 with LATS1-PPxY1. We solved the NMR 
structures of these complexes and identified several conserved residues that play 
a critical role in binding. We further created a YAP2 mutant by swapping the WW 
domains, and found that YAP2 phosphorylation at S127 by LATS1 is not affected by 
the spatial configuration of its WW domains. This is likely because the region between 
the PPxY motifs of LATS1 is unstructured, even upon binding with its partner. Based 
on our observations, we propose possible models for the interaction between YAP2 
and LATS1.
INTRODUCTION
The Hippo tumor suppressor pathway plays a critical 
role in regulating cell proliferation and apoptosis [1, 2]. 
First discovered in Drosophila [3, 4], the core components 
of the pathway are highly conserved throughout evolution, 
with loss-of-function mutants of core pathway components 
resulting in tissue overgrowth and a diminished cell death 
phenotype [5]. The pathway has therefore been associated 
with a wide range of physiological and pathological 
conditions, including cancer [6], tissue regeneration 
and wound healing [2]. The Hippo pathway has been 
extensively reviewed [5, 7–9]. In short, it involves a 
cascade of phosphorylation events that culminate in the 
phosphorylation and deactivation of the transcriptional co-
activators, YAP and TAZ, by the LATS serine/threonine 
kinases. Phosphorylated YAP and TAZ are sequestered 
into the cytoplasm via several known mechanisms [6, 8] 
to inhibit the transcription of their target genes. Both YAP 
and TAZ promote cell growth and inhibit cell death, and 
are thus regarded as potent oncoproteins.
Numerous complexes in the Hippo pathway are 
mediated by WW domains and their recognition motifs 
[10]. WW domains are typically 35 to 40 amino acids in 
length, and are characterized by two highly conserved 
tryptophan (W) residues separated by 20 to 23 amino acids 
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[11]. They fold into a typical triple-stranded anti-parallel 
β-sheet and interact with proline-rich motifs, such as PPxY 
(where P is proline, Y is tyrosine and x is any amino acid) 
[11]. Despite the conservation in their structure, WW 
domains within different proteins show ligand-specific 
interactions [12]. These interactions are further influenced 
by combinations of tandem WW domains and PPxY 
motifs in some proteins, which lead to selectivity between 
partners during signal transduction [13].
The Hippo pathway effector, YAP has two major 
isoforms, YAP1-1 (abbreviated as YAP1), which has a 
single WW domain, and YAP1-2 (abbreviated as YAP2), 
which contains two WW domains separated by a linker 
of 20 to 25 amino acids [14]. The LATS kinase is also 
reported to have two isoforms: LATS1, with two PPxY 
motifs separated by 180 amino acids, and LATS2, with 
only one PPxY motif [15]. YAP and LATS interact through 
their WW domains and PPxY motifs, respectively, and 
mutations in these regions abrogate their binding [16, 17]. 
However, the importance of these tandem domains and 
motifs in the specific YAP2 and LATS1 isoforms and the 
bearing this has on their interaction is not fully understood. 
Here, we report the structural, biophysical and cell-
based studies of YAP2 WW domains and LATS1 PPxY 
motifs to understand their interaction. We find that the 
first WW domain of YAP2 exhibits a preference for the 
second PPxY motif of LATS1, whereas the second WW 
domain of YAP2 prefers the first motif of LATS1. We 
solved the NMR structures of the complexes between WW 
domains and PPxY-containing peptides, and identified key 
residues that are important for the interactions. We show 
that swapping the WW domains of YAP2 has no effect 
on the phosphorylation status of its highly conserved 
phosphorylation site, S127, by LATS1. Furthermore, we 
show that the region between the two PPxY motifs of 
LATS1 is unstructured, which may regulate its protein-
interaction profile. Collectively, these studies widen our 
understanding of the molecular basis for the interaction 
between LATS1 and YAP2.
RESULTS
YAP2 WW domains exhibit binding preference 
for LATS1 PPxY motifs
We first performed isothermal titration calorimetry 
(ITC) to test for binding preferences between the two WW 
domains of YAP2 and the two PPxY motifs of LATS1 
(Figure 1A). The individual WW domains (WW1 and 
WW2) were titrated against peptides containing the PPxY 
motifs from LATS1, NRQPPPPYPLTA (PPxY1) and 
NYQGPPPPYPKH (PPxY2) (Figure 1A).
Among the combinations, the binding affinity 
was highest between WW1 and PPxY2, with a Kd of 
4.2 µM (Figure 1B left and 1C). This suggests that 
WW1 has a binding preference for the second PPxY 
motif from LATS1. Further, we found that WW2 showed 
a higher affinity for the first PPxY motif, with a Kd of 
11 µM (Figure 1B right and 1C) as compared with 29 
µM for WW2-PPxY2 or 15 µM for WW1-PPxY1 (Figure 
1C, Supplementary Figure 1). A similar observation of 
preferential binding for YAP2 WW domains with PPxY 
peptides of other proteins has been reported elsewhere 
[18]. Previous work has also shown that mutation of 
either of the domains or motifs weakens the interaction 
between YAP2 and LATS1, and that mutations of both 
WW domains [16] or both PPxY motifs [17] completely 
abolishes the interaction. This suggests that both domains 
and motifs are involved in mediating the interaction. 
Based on our ITC results, we suggest that YAP2-WW1 
and LATS1-PPxY2 form the basis of the interaction while 
WW2 and PPxY1 act as additional regulators for their 
binding.
NMR structures of WW1-PPxY2 and WW2-
PPxY1
Next, to understand the basis of these preferential 
interactions, we solved the complex structures using 
NMR. The binding affinity for the complexes was in the 
micro-molar range and the complex partially dissociated 
upon injection into gel filtration chromatography 
(Supplementary Figure 2). Thus, to prevent complex 
dissociation, we linked the peptides to their respective 
domains (WW1-PPxY2 and WW2-PPxY1), thereby 
maintaining homogeneity of the sample. Further, because 
the complex would be expressed as a single protein, this 
aided in labelling the peptides with 15N and 13C. 
Poly-glycine linkers can be used to trap weak and 
transient protein interactions for structural studies [19, 20]. 
We therefore attempted a range of poly-glycine linkers (of 
4 to 8 glycine residues) and compared their gel filtration 
elution profiles. We anticipated that the complex with 
an optimum linker length would elute similarly to the 
unlinked complex. The complex with a 4-glycine linker 
eluted at the same volume as the unlinked complex, 
whereas the longer linked constructs eluted at slightly 
larger volumes (Supplementary Figure 2). The 4-glycine 
linker was therefore selected for structure determination.
The structures of both linked complexes, WW1-
PPxY2 and WW2-PPxY1, were solved using NMR 
and refined to final backbone RMSD of 0.20Å in the 
secondary structure region for the 20 lowest energy 
structures (Table 1). The WW domains exhibit the typical 
structure comprising of a triple-stranded anti-parallel 
β-sheet. The glycine linker forms an unstructured loop that 
holds the peptide in close vicinity to the domain (Figure 
2A). The PPxY peptides are present in polyproline type 
II (PPII) helical conformation. There are two pockets that 
recognize the PPxY peptide, one for P1 and the other for 
Y (Figure 2B). In the WW1-PPxY2 complex, a total of 
41 NOEs were observed between the domain and peptide, 
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among residues corresponding to the two binding pockets. 
The P1 pocket is formed by the side chains of W199 and 
T197 (Figure 3A left), with a hydrogen bond contact 
(3Å) between the indole nitrogen of W199 as donor and 
the backbone nitrogen of P1 as acceptor. The Y pocket 
is a hydrophobic groove composed of side chains from 
L190, H192, Q195, and T197 that fits the Y side chain 
from the PPxY peptide (Figure 3A right). The total buried 
surface area between domain and peptide is 796Å2. In the 
WW2-PPxY1 complex, 25 NOEs were observed between 
the domain and peptide. The P1 pocket is composed of 
W258 and T256 (Figure 3B left), whereas the Y pocket 
is formed by I249, H251, K254, and T256 (Figure 3B 
right), with a total buried surface area of 630Å2. It should 
be noted that the P1 and Y pockets in both domains are 
formed by corresponding residues from each domain, and 
the difference in buried surface area is consistent with 
their binding affinities. The two WW domains are 53% 
identical and 71% similar in sequence. Therefore, both 
complexes are similar and superimpose with an RMSD of 
0.92Å for all Cα atoms in the secondary structure region 
(Supplementary Figure 3), and are consistent with other 
known WW structures [21–25].
Additional key residues from WW domains are 
important for interaction
Since WW1 and PPxY2 exhibited the highest 
binding affinity, we investigated this complex further. The 
NMR structure revealed that L190, H192, Q195, T197, 
and W199 of WW1 interact with the PPxY peptides. 
Previous studies have shown that W199 is a critical 
residue in the WW domain, as its mutation abrogates WW-
PPxY binding [26]. We thus sought to characterise the role 
of the additional residues that are involved in mediating 
the interaction. We mutated each of the aforementioned 
Figure 1: Preference between YAP2 WW domains and LATS1 PPxY peptides. (A) Schematic representations showing the 
WW domains from human YAP2 and PPxY peptides from LATS1. (B) ITC isotherms for WW1-PPxY2 (left) and WW2-PPxY1 (right) 
exhibiting the highest binding affinities. (C) Summary of thermodynamic parameters for binding among all combinations of YAP2 WW 
domains and LATS1 PPxY peptides.
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residues to alanine and performed ITC (Figure 4A and 
4B, Supplementary Figure 4). We found that L190A and 
H192A produced the maximal effect on binding, causing 
26- and 23-fold reductions in affinity, respectively, 
whereas T197A reduced the affinity by 10-fold and 
Q195A reduced the affinity by 3-fold. Therefore, all these 
residues are important for the interaction, with L190 and 
H192 being the most important among them. Similarly, 
the WW2-PPxY1 structure revealed that these residues are 
conserved, and mediate similar interactions with PPxY1.
Role of flanking residues of the PPxY motif in 
recognition
In both cases, the LATS1 PPxY peptides contain 
the same ‘PPPPYP’ sequence, differing only by the 
flanking residues. Yet, these two peptides exhibit different 
binding affinities to the two WW domains. This suggests 
that flanking residues might play an important role in 
mediating peptide recognition. Based on our structures, 
we observed that R from PPxY1 (P1-3) and Q from PPxY2 
(P1-3) make contact (3 to 3.5 Å) with the WW domains. 
We subsequently mutated each of these residues to alanine 
to examine their roles in binding. ITC experiments were 
performed with WW1, as it showed the highest affinity 
in previous experiments. In the case of PPxY1R→A, 
the Kd changed from 15 µM to 14 µM, whereas the Kd 
of PPxY2 Q→A changed from 4.2 to 4.4 µM (Figure 4C, 
Supplementary Figure 5). As the observed change is 
negligible, it is likely that other residues might be involved 
in the recognition. 
Swapping the YAP2 WW domains does not affect 
S127 phosphorylation
Upon activation by MST kinases, LATS1 
phosphorylates YAP2 on several residues, amongst which 
S127 is highly conserved [27, 28]. Using this site as 
reference, we tested whether the spatial arrangement of 
the two WW domains in YAP2 would affect the efficiency 
Table 1: Summary of NMR data and structure statistics
WW1-PPxY2 WW2-PPxY1
NOE distance restraints a 
 Intra-residue
 Sequential (|i–j| = 1)
 Medium range (1 <|i–j|<5)
 Long range (|i–j|≥5)
Hydrogen bond restraints






















Deviations from idealized covalent geometry
 R.m.s. deviations of bond lengths (Å)
 R.m.s. deviations of bond angles (°)







Deviations from experimental restraints
 R.m.s. deviations of distance restraints (Å)





Ramachandran plot analysis (%) c
 Residues in allowed regions
 Residues in generously allowed regions














a Distance restraints were obtained by classifying the NOE cross peaks into three categories: strong (1.8–2.9 Å), medium 
(1.8–3.5 Å), and weak (1.8–5.0 Å).
b Dihedral angles of backbone ϕ and ψ were predicted by TALOS [40] using the chemical shifts of Cα, Cβ, Hα, N, and HN.
c Calculated with PROCHECK-NMR [42].
d Calculated with MOLMOL [43] over secondary structure region β1 (177-181), β2 (187-191) and β3 (196-198) for WW1-
PPxY2 and β1 (236-240), β2 (246-249) and β3 (255-257) for WW2-PPxY1.
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of phosphorylation by LATS1. We created a YAP2 mutant, 
YAP2m in which the two WW domains were swapped 
(Figure 5A). Upon altering their configuration, the binding 
of LATS1 and YAP2m might result in the LATS1 kinase 
domain being differently positioned compared to wildtype 
YAP2. This would in turn affect the kinase activity of 
LATS1. We tested this in HEK-293T cells using full length 
wildtype YAP2 and mutant YAP2m. Interestingly, we 
observed no significant difference in LATS1 activity, with 
similar levels of S127 phosphorylation observed for the 
wildtype and mutant YAP2 (Figure 5B and 5C). From this, 
we hypothesized that the region between the two PPxY 
motifs of LATS1 is disordered and may be able to alter its 
shape depending on its binding partner.
Region between PPxY motifs in LATS1 is 
unstructured
We conducted further NMR experiments to examine 
how the LATS1 binding region changes upon association 
with its partner. 15N-labelled PY12 (containing both PPxY 
motifs; aa 361–567) was titrated against unlabeled WW12 
(containing both WW domains; aa 163–266). The HSQCs 
of the free and bound PY12 were compared to observe 
changes in the peaks. The HSQC of free PY12 shows 
that the protein is unstructured, as most of the peaks are 
clustered together around the 1H chemical shift 8 ppm 
(Figure 6A green). Upon the addition of the WW12 (final 
molar ratio of 1:5), there is no significant change in the 
structure of PY12, with a shift in only a few peaks (Figure 
6A red). From our structures, we know that the interacting 
region between the WW domains and the LATS1 peptides 
includes only prolines, the tyrosine, and a few residues 
from the flanking region of the PPxY motif. Prolines are 
not visible in HSQC and therefore only the remaining few 
residues appear shifted. This indicates that PY12 interacts 
with WW12 primarily through the PPxY motif, while the 
rest of the protein remains unstructured. 
Similarly, we repeated the NMR titration with 
15N-labelled WW12 and unlabelled PY12 to show that the 
two proteins were interacting with each other. The WW12 
HSQC changed significantly upon interaction with PY12 
Figure 2: NMR structures of WW1-PPxY2 and WW2-PPxY1 complex. (A) Structure alignment of the 20 lowest energy 
structures showing the folded WW domains and unstructured glycine linker holding PPxY peptides interacting with the WW domains (Left: 
WW1-PPxY2; Right: WW2-PPxY1). (B) Molecular surface representation of WW domains bound to the peptides shown in ribbon form. 
Key interactions of proline (P1) and tyrosine (Y) from PPxY motif are shown fitting into their respective pockets in the WW domains (Left: 
WW1-PPxY2; Right: WW2-PPxY1).
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(Figure 6B). This is because several amino acids from 
both WW1 and WW2 are involved in the interaction with 
the PPxY motifs, as seen in the structures of the domain-
motif complexes.
Finally, when the two constructs (WW12 and 
PY12) were co-expressed in E. coli, they formed a tight 
complex that could be purified using affinity and gel 
filtration chromatography (Figure 6C), indicating that the 
two proteins indeed interacted with high affinity. ITC was 
performed to determine the thermodynamic parameters 
of the WW12-PY12 interaction (Figure 6D). The Kd was 
determined to be 9.6 µM, which lies within the range of 
individual domain-peptide interactions (Figure 1C). 
DISCUSSION
WW domains and their interaction with proteins that 
contain PPxY motifs has held significant interest in the 
signaling field for over two decades [29]. WW domains 
are known to regulate the interactions of numerous 
proteins and, in some cases, even compete against each 
other [30]. Studies have shown that tandem WW domains 
are more selective compared with autonomous WW 
domains, leading to differential binding properties [31, 
32]. Other studies have shown that, in protein complexes 
with multiple WW domains and PPxY motifs, one of the 
domain-motif combinations is usually favored, with the 
other combination(s) acting as additional or supplemental 
regulators [13, 24]. Indeed, in vitro studies show that 
PPxY peptides bind different WW domains with varying 
affinities [18, 24, 33].
LATS1 interacts with several WW domain-
containing proteins via its PPxY motifs, including the 
Hippo pathway effector, YAP. Our ITC data showed 
that WW1 of YAP2 preferentially binds PPxY2 from 
LATS1 and vice-versa, suggesting that WW1-PPxY2 
binding forms the basis of the interaction, with additional 
regulation from WW2-PPxY1 binding. Once the first 
attachment is established between WW1 and PPxY2, 
the WW2-PPxY1 interaction would be further favoured 
and its binding affinity would increase, since the roto-
translational entropic penalty would be lower. Also, the 
WW1 domain is conserved among the other isoforms of 
YAP that contain only a single domain, indicating that 
WW1 is functionally more important for YAP interactions, 
making it a potential target for drug design. 
Mutation of key residues from YAP2 WW1 revealed 
that leucine (L190) and histidine (H192) are important 
for binding. Sequence alignment of WW domains from 
other proteins [23] shows that L190 is usually replaced by 
Figure 3: Interactions between WW domains and PPxY peptides. (A) Interactions of PPxY2 (yellow) motif with WW1 (green) 
domain showing the P1 and Y pockets. P1 side chain is sandwiched between W199 and T197, whereas the Y side chain is accommodated in 
the hydrophobic groove formed by L190, H192, Q195, and T197 from the domain. (B) PPxY1 (magenta) motif showing similar interactions 
with WW2 (orange) domain.
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either isoleucine or valine while H192 is highly conserved 
in other WW domains. We can therefore extrapolate that 
these conserved residues play a key role in the interaction 
of WW domains with PPxY peptides. Mutation of residues 
flanking the PPxY motif did not affect their binding 
affinity, suggesting that other residues from the motif may 
be involved. Studies on alanine-scanning mutagenesis 
of PPxY-containing peptides from ErbB4 also indicated 
that flanking residues do not affect its binding with WW 
domains dramatically [34]. The authors [34] proposed 
that the non-consensus residues may not be required for 
driving their interaction with WW domains but may play 
a role in stabilizing the conformation of PPxY peptides.
Recently, structures of WW domains in complex 
with PPSY and PPCY motifs were reported [24, 35]. 
We compared these structures with our WW1-PPPY2 
structure to examine the differences due to the presence 
of a different amino acid in PPxY. In both cases, the 
binding affinity between the domains and peptides was 
3 to 4 µM. Interestingly, the conformation of the peptides 
changed from PPII to 310 helical conformation, following 
the S/C residues (Supplementary Figure 6). The structural 
alignment shows that the side chains of these residues are 
present in a very similar conformation (Supplementary 
Figure 6). In case of S, there is a hydrogen bond with i+3 
residue that stabilizes the 310 helix. This further suggests 
that in addition to recognition, these residues play a role 
in stabilizing the peptide fold.
Although the role of YAP as a substrate of LATS1 
is well documented [16, 17], the molecular basis for their 
interaction is not fully understood. Secondary structure 
predictions from the protein sequence indicate that LATS1 
Figure 4: Identification of additional residues from WW domains and PPxY peptides. (A) ITC isotherms for WW1 mutants, 
L190A (left) and H192A (right), which displayed maximum decrease in the binding affinity with PPxY2. (B) Summary of thermodynamic 
parameters for binding between all WW1 mutants and PPxY2 peptide. (C) Thermodynamic parameters for binding between PPxY2 peptide 
mutants and WW1 domain.
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is largely disordered except for its C-terminal kinase 
domain. Our NMR experiments also confirm that the 
region between the PPxY motifs (PY12) is unstructured, 
even upon binding to its partner. Furthermore, we found 
that LATS1-mediated S127 phosphorylation is not 
affected by swapping the two WW domains in YAP2. It is 
therefore possible that there is no directionality between 
the domains and motifs of YAP2 and LATS1, and that a 
specific orientation of the WW domains is not required for 
LATS1 binding and phosphorylation at S127. However, 
this possibility is less likely because of the differential 
binding affinities of the WW domains-PPxY peptides. 
Although the YAP2 mutant should be tested for other 
phosphorylation sites in YAP2, based on our observations, 
Figure 5: Effect of WW domain swapping in YAP2 on its phosphorylation by LATS1. (A) Schematic representations of 
wildtype YAP2 (blue) and mutant YAP2m (purple) with swapped WW domains. (B) HEK293T cells were co-transfected with myc-MST2, 
LATS1, and either YAP2 wildtype or mutant constructs, as indicated. After 24 h cell lysates were harvested, separated by SDS-PAGE, 
transferred to membranes, and immunoblotted for myc, LATS1, YAP, phospho-YAP S127, and the loading control β-actin. Size markers are 
shown in kDa. Band intensities for YAP and phospho-YAP S127 (indicated by numbers in blue) were quantitated using Bio-Rad Image Lab 
software relative to lane 1. A representative image from one experiment. (C) Fold-change increase in phospho-YAP S127 band intensity by 
the co-transfection of LATS1. Data represents the mean and standard deviation for three independent experiments. 
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we make two speculations as to the binding. First, because 
the region between the PPxY motifs (PY12) of LATS1 is 
unstructured, the motifs may rearrange themselves as per 
the orientation of the WW domains, thereby maintaining 
the correct spatial configuration of the LATS1 kinase 
domain and not interfering with its phosphorylation 
activity (Figure 7B). Second, the LATS1 region between 
PY12 and the kinase domain (aa 568-704) may be flexible, 
allowing the kinase domain to access different regions of 
its binding partner (Figure 7C).
In summary, our studies reveal that YAP2 WW 
domains prefer different LATS1 PPxY motifs in vitro. 
Besides the conserved tryptophan, leucine (L190) and 
histidine (H192) are conserved residues in WW domains 
and play critical roles in their interaction with PPxY 
motifs. There is a putative functional conservation 
of S127 phosphorylation of YAP2 by LATS1 kinase 
that is independent of the configuration of the WW 
domains in the YAP2 and LATS1 complex. LATS1 is 
mainly unstructured, and this property may regulate its 
interactions with different binding partners.
MATERIALS AND METHODS
Cloning, expression and purification of proteins
The YAP2 sequences WW1 (aa 163-206), WW2 
(aa 227-266), WW12 (containing both WW domains; aa 
163-266), WW1-4gly-PPxY2, WW2-4gly-PPxY1 and 
all WW1 mutants were cloned into pGEX-6P-1. LATS1 
region PY12 (containing both PPxY motifs; aa 361-567) 
was cloned into pACYC. Full-length LATS1, YAP2, and 
YAP2m, with swapped WW domains (residues mentioned 
above) were cloned into pcDNA3.1(-). 
Constructs were transformed into E. coli BL21 
(DE3) cells and grown in LB media at 37°C to OD600 0.6 to 
0.8. Protein expression was induced by the addition of 0.2 
mM IPTG and the cultures were grown at 20°C overnight. 
For 15N- and 13C-labelled samples, cultures were grown in 
M9 media containing 15NH4Cl and 
13C-glucose. 
Cells were harvested by spinning at 4,000 g for 
20 min and lysed by sonication in buffer containing 
50 mM Tris-HCl pH 7.0, 200 mM NaCl, 5% glycerol, 
2 mM DTT, 0.5% Triton X-100 and 1mM PMSF. The 
lysates were centrifuged at 30,000 g for 30 min at 4°C 
and the supernatant was subjected to GST affinity 
chromatography. The GST tag was cleaved overnight 
using PreScission Protease. In the case of WW12-PY12 
complex, an additional Ni-NTA chromatography step 
was performed, as PY12 contained a His-tag. The eluted 
proteins were further purified using FPLC Superdex 75 
gel filtration in buffer containing 20 mM Tris-HCl pH 7.0, 
100 mM NaCl, 5% glycerol and 2 mM DTT. The purity 
and quality of the purified proteins were assessed using 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) and 
dynamic light scattering (DLS).
Figure 6: PY12 region from LATS1 is unstructured. (A) Comparison between HSQC of free PY12 (green) and WW12-bound 
PY12 (red). (B) Comparison between HSQC of free WW12 (green) and PY12-bound WW12 (red) (C) Gel filtration elution profile of 
WW12-PY12 complex, and SDS-PAGE showing WW12 and PY12 at their corresponding molecular weights. Size markers are shown in 
kDa. (D) ITC titration and thermodynamic parameters for the interaction between WW12 and PY12. 
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Isothermal titration calorimetry (ITC)
ITC experiments were performed using the 
MicroCal VP-ITC titration calorimeter (MicroCal-
Malvern). The LATS1 peptides containing PPxY 
motifs, NRQPPPPYPLTA (PPxY1; aa 369-380) 
and NYQGPPPPYPKH (PPxY2; aa 551-562) and 
their mutants, NAQPPPPYPLTA (PPxY1m) and 
NYAGPPPPYPKH (PPxY2m), were obtained from GL 
BioChem. The proteins and peptides used were prepared 
in the same buffer containing 20 mM Tris-HCl pH 7.0 and 
100 mM NaCl. Protein concentrations varying from 20 to 
70 µM were titrated against peptide concentrations ranging 
from 0.5 to 1.8 mM at 25°C. The peptide samples were 
also injected into buffer as a reference to estimate the heat 
of dilution. In the case of WW12 vs PY12, the buffer used 
was 20 mM Tris-HCl pH 7.0, 100 mM NaCl, 3% glycerol, 
2 mM DTT and 2 mM EDTA. All samples were degassed 
and spun before the experiment. The binding isotherms 
were analyzed employing a model that considered a single 
ligand binding site implemented in Origin 7 (OriginLab). 
Linking WW domains with PPxY peptides
The linked complexes of WW1-PPxY2 and WW2-
PPxY1 were prepared using a poly-glycine linker. The 
glycines were inserted using fusion PCR by designing 
primers containing glycine sequence overhangs. Several 
lengths were tested, varying from 4 to 8 glycines. The 
optimum length was determined by comparing the elution 
profiles from analytical Superdex 75 gel filtration column.
NMR structure determination
The domain-peptide linked constructs labelled 
with 15N and 13C were exchanged into buffer containing 
20 mM sodium phosphate pH 6.0 and 100 mM NaCl. 
The samples were concentrated to 1 mM and D2O was 
added to a final concentration of 5%. Data collection 
was performed at 25°C using a Bruker Avance 800 MHz 
spectrometer equipped with a TXI cryogenic probe. 
1H, 15N, and 13C resonance assignments were obtained from 
3D HNCACB, 3D CBCA(CO)NH [36], and 3D HCCH-
TOCSY spectra [37]. Inter-proton distance restraints for 
Figure 7: Schematic representation to show the proposed models for the interaction between YAP2 and LATS1. YAP2: 
blue; YAP2m: purple; LATS1: dotted red; WW1: green; WW2: orange; PPxY1: magenta; PPxY2: yellow. (A) LATS1 interacting with 
wildtype YAP2 via PPxY motif-WW domain interactions, resulting in phosphorylation at S127. (B) LATS1 interacting with YAP2m, 
containing swapped WW domains. The region between the PPxY motifs in PY12 is unstructured and might re-arrange depending on 
the orientation of WW domains, thereby maintaining the same spatial configuration of LATS1 kinase domain as wildtype YAP2. (C) 
Alternatively, the spatial position of LATS1 kinase domain may change upon interaction with YAP2m. However, the LATS1 region between 
PY12 and kinase domain (aa 568-704) may be flexible, allowing the kinase domain to phosphorylate different regions of YAP2.
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structure calculation were assigned from 3D 15N-edited 
NOESY-HSQC, 3D 13C NOESY-HSQC, and 2D 1H-1H 
NOESY spectra using a 100 ms mixing time. All spectra 
were processed by NMRPipe/NMRDraw [38] and data 
analysis was done using Sparky [39]. Dihedral angle 
restraints were predicted by the TALOS program [40]. 
The solution structures (100) were calculated using the 
Xplor-NIH 2.24 software package [41], using 10,000 steps 
of simulated annealing and ensembles of the 20 lowest 
energy structures were selected. 
NMR titration
WW12 and PY12 were individually labelled with 
15N and purified in buffer containing 20 mM Tris-HCl pH 
7.0, 50 mM NaCl, 3% glycerol, 5 mM DTT and 2 mM 
EDTA. The samples were concentrated ranging from 400 
to 500 µM, and D2O was added to a final concentration 
of 5%. The labelled samples were then titrated against 
their unlabelled partners to a final molar ratio of 1:5. The 
HSQC spectra were measured as mentioned previously. 
Cell culture and transfection
HEK-293T cells (purchased from ATCC) were 
grown in DMEM medium (Nacalai Tesque), supplemented 
with 10% fetal bovine serum (FBS, HyClone) and 100U/
mL penicillin/streptomycin (Nacalai Tesque).
Sub-confluent 60 mm dishes of HEK-293T 
cells were co-transfected with 1.3 μg of pCI-neo-myc-
hMST2 (a gift from Wanjin Hong and Lim Yoon Pin), 
1.3 μg of pcDNA3.1(-)-YAP2 wildtype or mutant, 1.3 
μg of pcDNA3.1(-)-LATS1, and 1.3 μg of pcDNA3.1(-)-
empty vector as required to make the total DNA to 3.94 μg, 
using TransIT-293 Transfection Reagent (Mirus) according 
to the manufacturer’s specifications. After 24 h, cells were 
lysed in 400 μL of immunoprecipitation buffer (50 mM 
Tris pH 8.0, 150 mM NaCl, 1% (v/v) NP-40 containing 
1:100 protease inhibitor cocktail (Sigma-Aldrich) and 
1:100 phosphatase inhibitor cocktail (Sigma-Aldrich). 
Samples were rotated at 4°C for 1 h before centrifugation 
at 16,000 g for 10 min. Lysates were quantitated using 
Bio-Rad Protein Assay Reagent.
Western blotting
Protein lysates (30 μg of total protein) were boiled 
in sample buffer (2% (w/v) SDS, 10% (v/v) glycerol, 
62.5 mM Tris pH 6.8, 0.02% (w/v) bromophenol blue, 
with 1% (v/v) 2-mercaptoethanol) and separated by SDS-
PAGE using linear Tris-glycine gels in running buffer 
(25 mM Tris pH 8.3, 192 mM glycine, 0.1% SDS (w/v)) 
using the Mini-PROTEAN Tetra Cell system (Bio-Rad). 
The Bio-Rad Precision Plus Protein All Blue Pre-Stained 
Standards (Cat. 161-0373) was used as the molecular 
weight reference.
Separated proteins were transferred to Immun-
Blot PVDF membranes (Bio-Rad Cat. 162-0177) using 
the Mini Trans-Blot Cell system (Bio-Rad) at 90 V for 
90 min at 4°C in transfer buffer (25 mM Tris-base, 192 
mM glycine, 20% (v/v) methanol). Membranes were then 
washed with Tris- buffered saline containing Tween-20 
(TBST; 25 mM Tris pH 7.5, 150 mM NaCl, 0.1% (v/v) 
Tween-20) and then blocked with 5% (w/v) skim milk 
powder in TBST for 30 min at room temperature. Blotting 
was performed with primary antibodies overnight at 4°C. 
Membranes were washed four times for 5 min each with 
TBST and then incubated with secondary antibody for 1 
h at room temperature, before washing again with TBST. 
Signals were detected using the Bio-Rad ChemiDoc 
Touch Imaging System with WesternBright Quantum 
Western Blotting HRP Substrate (Cat. K-12042-D10). 
Band intensity was quantitated using Bio-Rad Image lab 
software.
Antibodies
The following antibodies were used: anti-myc 
(Santa Cruz Biotechnology, Cat. sc789), anti-LATS1 
(Abcam, Cat. ab70561), anti-phospho-YAP S127 (Abcam, 
Cat. ab76252), anti-YAP (made in house as described in 
[17]), and Anti-β-Actin (Cell Signaling Technology, Cat. 
3700).
Accession numbers
The structure coordinates have been deposited at the 
Protein Data Bank (PDB) with the accession codes 5YDX 
for WW1-PPxY2 and 5YDY for WW2-PPxY1.
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